Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Scott

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 17, 1999
Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trialsJ D Cox, C B Scott, R W Byhardt, et al.
Cancer|February 15, 1993
Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28B E Epstein, C B Scott, W T Sause, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1991
Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03L Tupchong, C B Scott, P H Blitzer, et al.
Cancer|April 15, 1996
Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02M Werner-Wasik, C B Scott, D F Nelson, et al.
Cancer|December 25, 1992
A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02W J Curran, C B Scott, J S Nelson, et al.
Journal of the National Cancer Institute|May 5, 1993
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trialsW J Curran, C B Scott, J Horton, et al.
Journal of Neuro-Oncology|March 11, 1992
Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trialsW J Curran, C B Scott, J Horton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02W J Curran, C B Scott, A S Weinstein, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1993
Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck databaseG E Laramore, C B Scott, D E Schuller, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034G E Laramore, C B Scott, M al-Sarraf, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|March 17, 1999
Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trialsJ D Cox, C B Scott, R W Byhardt, et al.
Cancer|February 15, 1993
Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28B E Epstein, C B Scott, W T Sause, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1991
Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03L Tupchong, C B Scott, P H Blitzer, et al.
Cancer|April 15, 1996
Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02M Werner-Wasik, C B Scott, D F Nelson, et al.
Cancer|December 25, 1992
A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02W J Curran, C B Scott, J S Nelson, et al.
Journal of the National Cancer Institute|May 5, 1993
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trialsW J Curran, C B Scott, J Horton, et al.
Journal of Neuro-Oncology|March 11, 1992
Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trialsW J Curran, C B Scott, J Horton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02W J Curran, C B Scott, A S Weinstein, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1993
Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck databaseG E Laramore, C B Scott, D E Schuller, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034G E Laramore, C B Scott, M al-Sarraf, et al.
Pageof 9